Chugai Pharmaceutical
TSE:4519 Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 1 Fair Values set on narratives written by author
AN
Consensus Narrative from 15 Analysts
Accelerating RED Capabilities And Robust Pipeline Will Enhance Future Prospects
Key Takeaways Emphasis on RED capabilities and innovative products aims to drive revenue growth and improve net and operating margins. Overseas sales, particularly Hemlibra, and strategic lifecycle management will sustain growth and enhance future earnings potential.
View narrativeJP¥7.84k
FV
12.3% undervalued intrinsic discount3.56%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
3 days ago author updated this narrative